NAMI
MIRM icon

Nomura Asset Management International’s Mirum Pharmaceuticals MIRM Stock Holding History

Nomura Asset Management International’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88M Buy
752,044
+346,723
+86% +$34.8M 0.13% 192
2026
Q1 		$37.4M Sell
405,321
-16,524
-4% -$1.55M 0.06% 404
2025
Q4 		$33.3M Buy
+421,845
New +$30.3M 0.05% 457

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nomura Asset Management International's MIRM Position: Q2 2026 in Review

Nomura Asset Management International increased its Mirum Pharmaceuticals (MIRM) stake by 86% in Q2 2026, buying an estimated $34.8M and bringing the position to 752,044 shares worth $88M. The position accounts for 0.13% of the portfolio, ranked #192.

Nomura Asset Management International first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Nomura Asset Management International held 752,044 shares of Mirum Pharmaceuticals worth $88M as of Q2 2026.
  • Nomura Asset Management International bought 346,723 Mirum Pharmaceuticals shares in Q2 2026, an estimated $34.8M.
  • Mirum Pharmaceuticals made up 0.13% of Nomura Asset Management International's portfolio in Q2 2026, its #192 holding.
  • Nomura Asset Management International first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.